GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lifeline Scientific Inc (LSE:LSI) » Definitions » Total Liabilities

Lifeline Scientific (LSE:LSI) Total Liabilities : £4.07 Mil (As of Jun. 2016)


View and export this data going back to . Start your Free Trial

What is Lifeline Scientific Total Liabilities?

Lifeline Scientific's Total Liabilities for the quarter that ended in Jun. 2016 was £4.07 Mil.

Lifeline Scientific's quarterly Total Liabilities increased from Jun. 2015 (£3.93 Mil) to Dec. 2015 (£4.21 Mil) but then declined from Dec. 2015 (£4.21 Mil) to Jun. 2016 (£4.07 Mil).

Lifeline Scientific's annual Total Liabilities increased from Dec. 2013 (£4.15 Mil) to Dec. 2014 (£4.71 Mil) but then declined from Dec. 2014 (£4.71 Mil) to Dec. 2015 (£4.21 Mil).


Lifeline Scientific Total Liabilities Historical Data

The historical data trend for Lifeline Scientific's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lifeline Scientific Total Liabilities Chart

Lifeline Scientific Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.77 4.05 4.15 4.71 4.21

Lifeline Scientific Semi-Annual Data
Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.84 4.71 3.93 4.21 4.07

Lifeline Scientific Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Lifeline Scientific's Total Liabilities for the fiscal year that ended in Dec. 2015 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=4.007+(0.019+0.183
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=4.21

Total Liabilities=Total Assets (A: Dec. 2015 )-Total Equity (A: Dec. 2015 )
=27.868-23.659
=4.21

Lifeline Scientific's Total Liabilities for the quarter that ended in Jun. 2016 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=3.826+(0.017+0.226
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=4.07

Total Liabilities=Total Assets (Q: Jun. 2016 )-Total Equity (Q: Jun. 2016 )
=30.398-26.329
=4.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lifeline Scientific Total Liabilities Related Terms

Thank you for viewing the detailed overview of Lifeline Scientific's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Lifeline Scientific (LSE:LSI) Business Description

Traded in Other Exchanges
N/A
Address
Lifeline Scientific Inc was incorporated on October 1, 1998. The Company is in the business of delivering, to targeted medical markets, a portfolio of related proprietary technologies, which include devices, solutions, and protocols designed to maximize the use and availability of organs, tissues, and cells. It serves the kidney transplant market today with its LifePort product line, and also sells solutions to service the broader organ transplant industry. The Company operates in North America, Brazil, China and Rest of World.